Barclays PLC grew its holdings in shares of Global Medical REIT Inc. (NYSE:GMRE – Free Report) by 87.1% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 154,051 shares of the company’s stock after purchasing an additional 71,704 shares during the quarter. Barclays PLC owned approximately 0.23% of Global Medical REIT worth $1,527,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently made changes to their positions in GMRE. Zacks Investment Management grew its stake in shares of Global Medical REIT by 12.9% during the 3rd quarter. Zacks Investment Management now owns 14,803 shares of the company’s stock valued at $147,000 after acquiring an additional 1,696 shares during the period. Principal Financial Group Inc. grew its stake in shares of Global Medical REIT by 7.2% during the 2nd quarter. Principal Financial Group Inc. now owns 30,107 shares of the company’s stock valued at $273,000 after acquiring an additional 2,033 shares during the period. Creative Planning grew its stake in shares of Global Medical REIT by 13.3% during the 3rd quarter. Creative Planning now owns 22,980 shares of the company’s stock valued at $228,000 after acquiring an additional 2,702 shares during the period. The Manufacturers Life Insurance Company grew its stake in shares of Global Medical REIT by 7.8% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 48,186 shares of the company’s stock valued at $438,000 after acquiring an additional 3,471 shares during the period. Finally, First Trust Direct Indexing L.P. grew its stake in shares of Global Medical REIT by 25.6% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 20,432 shares of the company’s stock valued at $202,000 after acquiring an additional 4,164 shares during the period. Hedge funds and other institutional investors own 57.52% of the company’s stock.
Analyst Ratings Changes
GMRE has been the subject of a number of recent research reports. Berenberg Bank started coverage on Global Medical REIT in a research note on Friday, October 18th. They set a “buy” rating and a $11.75 price objective for the company. Alliance Global Partners started coverage on Global Medical REIT in a research note on Thursday, September 19th. They issued a “buy” rating and a $12.00 price target for the company.
Global Medical REIT Trading Down 1.4 %
GMRE stock opened at $7.52 on Monday. Global Medical REIT Inc. has a 1-year low of $7.33 and a 1-year high of $10.83. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.28 and a quick ratio of 0.28. The company has a market capitalization of $502.36 million, a price-to-earnings ratio of -375.81, a PEG ratio of 1.46 and a beta of 1.23. The business has a 50 day simple moving average of $8.38 and a two-hundred day simple moving average of $9.04.
Global Medical REIT (NYSE:GMRE – Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.21 by ($0.18). The business had revenue of $34.26 million during the quarter, compared to the consensus estimate of $34.88 million. Global Medical REIT had a return on equity of 0.86% and a net margin of 3.23%. During the same quarter in the previous year, the company earned $0.23 earnings per share. Research analysts anticipate that Global Medical REIT Inc. will post 0.83 EPS for the current fiscal year.
Global Medical REIT Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 8th. Stockholders of record on Friday, December 20th were issued a dividend of $0.21 per share. The ex-dividend date of this dividend was Friday, December 20th. This represents a $0.84 annualized dividend and a dividend yield of 11.17%. Global Medical REIT’s dividend payout ratio (DPR) is -4,200.00%.
Global Medical REIT Profile
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
See Also
- Five stocks we like better than Global Medical REIT
- What Are Growth Stocks and Investing in Them
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- What is a support level?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Why Are Stock Sectors Important to Successful Investing?
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.